Biofrontera, which sells treatments for skin conditions caused by sun damage, raised $12 million by offering 1.2 million ADSs at $9.88. Biofrontera plans to list on the Nasdaq under the symbol BFRA. The Benchmark Company acted as a lead manager on the deal. Listed on the Frankfurt Stock Exchange (B8F), Biofrontera plans to raise an additional $17 million in Germany in a preemptive rights offering to existing shareholders.
